Synergistic effects of meloxicam and conventional cytotoxic drugs in human MG-63 osteosarcoma cells.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

• Publication date

  2007-07-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/J.BIOPHA.2007.02.011PMID 17395421
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Upregulation of Bcl-2 is associated with cisplatin-resistance via inhibition of Bax translocation in human bladder cancer cells.

  2006cited by this paper
• Meloxicam inhibits osteosarcoma growth, invasiveness and metastasis by COX-2-dependent and independent routes.

  2006cited by this paper
• Molecular requirements for doxorubicin-mediated death in murine oocytes

  2006cited by this paper
• Overexpression of COX-2 in human osteosarcoma cells decreases proliferation and increases apoptosis.

  2006cited by this paper
• DNA fragmentation as a consequence of cell cycle traverse in doxorubicin- and idarubicin-treated human lymphoma cells

  2005cited by this paper
• Combination of cyclooxygenase-2 inhibitors and oxaliplatin increases the growth inhibition and death in human colon cancer cells.

  2005cited by this paper
• Molecular pathways in the chemosensitization of cisplatin by quercetin in human head and neck cancer

  2005cited by this paper
• Cyclooxygenase-independent down-regulation of multidrug resistance–associated protein-1 expression by celecoxib in human lung cancer cells

  2005cited by this paper
• Cyclooxygenase-2 inhibitors reverse chemoresistance phenotype in medullary thyroid carcinoma by a permeability glycoprotein-mediated mechanism.

  2005cited by this paper
• The potential role of cyclooxygenase-2 inhibitors in the treatment of experimentally-induced mammary tumour: does celecoxib enhance the anti-tumour activity of doxorubicin?

  2004cited by this paper
• Cyclooxygenase-2 gene induction causes CDDP resistance in colon cancer cell line, HCT-15.

  2004cited by this paper
• Enhanced sensitivity of bladder cancer cells to cisplatin mediated cytotoxicity and apoptosis in vitro and in vivo by the selective cyclooxygenase-2 inhibitor JTE-522.

  2004cited by this paper
• Cyclooxygenase-2 (COX-2)-dependent and -independent anticarcinogenic effects of celecoxib in human colon carcinoma cells.

  2004cited by this paper
• Can Patients' Likelihood of Benefiting from Primary Chemotherapy for Breast Cancer Be Predicted Before Commencement of Treatment?

  2004cited by this paper
• Evaluation of An Aerosolized Selective COX-2 Inhibitor as a Potentiator of Doxorubicin in a Non-Small-Cell Lung Cancer Cell Line

  2003cited by this paper
• Inhibition of cyclooxygenase-2 by rofecoxib attenuates the growth and metastatic potential of colorectal carcinoma in mice.

  2003cited by this paper
• Cyclooxygenase-2 Expression Does Not Correlate With Outcome in Osteosarcoma or Rhabdomyosarcoma

  2003cited by this paper
• Heat- and 4-hydroperoxy-ifosfamide-induced apoptosis in B cell precursor leukaemias

  2003cited by this paper
• Celecoxib inhibits proliferation and induces apoptosis via prostaglandin E2 pathway in human cholangiocarcinoma cell lines.

  2003cited by this paper
• Combination chemotherapy with JTE-522, a novel selective cyclooxygenase-2 inhibitor, and cisplatin against gastric cancer cell lines in vitro and in vivo.

  2003cited by this paper
• c-Myc Is Necessary for DNA Damage-Induced Apoptosis in the G2 Phase of the Cell Cycle

  2001cited by this paper
• Dose-dependent modulation of apoptosis and cyclooxygenase-2 expression in human 1547 osteosarcoma cells by NS-398, a selective cyclooxygenase-2 inhibitor.

  2001cited by this paper
• Cyclophosphamide induces caspase 9-dependent apoptosis in 9L tumor cells.

  2001cited by this paper
• Indomethacin increases the cytotoxicity of cis-platinum and 5-fluorouracil in the human uterine cervical cancer cell lines SKG-2 and HKUS by increasing the intracellular uptake of the agents

  2001cited by this paper
• Over‐expression of cyclooxygenase‐2 in human prostate adenocarcinoma

  2000cited by this paper
• Cyclooxygenase-2 inhibitor induces apoptosis and enhances cytotoxicity of various anticancer agents in non-small cell lung cancer cell lines.

  2000cited by this paper
• Meloxicam inhibits the growth of non-small cell lung cancer.

  2000cited by this paper
• Synergistic effects of new chemopreventive agents and conventional cytotoxic agents against human lung cancer cell lines.

  1999cited by this paper
• NS398, a selective cyclooxygenase-2 inhibitor, induces apoptosis and down-regulates bcl-2 expression in LNCaP cells.

  1998cited by this paper
• Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer.

  1998cited by this paper
• Aspirin toxicity for human colonic tumor cells results from necrosis and is accompanied by cell cycle arrest.

  1998cited by this paper
• A possible role for multidrug resistance-associated protein in the secretion of basic fibroblast growth factor by osteogenic sarcoma cell line (MG-63).

  1998cited by this paper
• bcl-2 but not p53 expression is associated with resistance to chemotherapy in advanced breast cancer.

  1998cited by this paper
• Meloxicam inhibits the growth of colorectal cancer cells.

  1998cited by this paper
• Enhancement of chemotherapeutic drug toxicity to human tumour cells in vitro by a subset of non-steroidal anti-inflammatory drugs (NSAIDs).

  1998cited by this paper
• Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2.

  1997cited by this paper
• Involvement of the CD95 (APO–1/Fas) receptor/ligand system in drug–induced apoptosis in leukemia cells

  1996cited by this paper
• Cellular responses to cisplatin. The roles of DNA-binding proteins and DNA repair.

  1994cited by this paper
• Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas.

  1994cited by this paper
• Wild-type p53-triggered apoptosis is inhibited by bcl-2 in a v-myc-induced T-cell lymphoma line.

  1993cited by this paper
• Myc-mediated apoptosis is blocked by ectopic expression of Bcl-2

  1993cited by this paper
• Adriamycin and daunomycin induce programmed cell death (apoptosis) in tumour cells.

  1993cited by this paper
• Effects of CPT‐11 in combination with other anti‐cancer agents in culture

  1992cited by this paper
• The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity.

  1986cited by this paper
• Exploitable mechanisms in combined radiotherapy-chemotherapy: the concept of additivity.

  1979cited by this paper

• Effect of Meloxicam on the Proliferation and Apoptosis of the Raji Cell Line: an In Vitro Study

  2022cites this paper
• Heterocycles in Breast Cancer Treatment: The Use of Pyrazole Derivatives

  2022cites this paper
• Interactions of Analgesics with Cisplatin: Modulation of Anticancer Efficacy and Potential Organ Toxicity

  2021cites this paper
• Metal complexes of NSAIDs as potent anti-tumor chemotherapeutics: Mechanistic insights into cytotoxic activity via multiple pathways primarily by inhibition of COX–1 and COX–2 enzymes

  2021cites this paper
• Alantolactone inhibits proliferation, metastasis and promotes apoptosis of human osteosarcoma cells by suppressing Wnt/β-catenin and MAPKs signaling pathways

  2020cites this paper
• Cytotoxicity of Platinum and Palladium Chelates against Osteosarcoma

  2020cites this paper
• Elucidating the mechanisms of action of parecoxib in the MG-63 osteosarcoma cell line

  2020cites this paper
• Inhibitory Effects of Indomethacin in Human MNNG/HOS Osteosarcoma Cell Line In Vitro

  2019cites this paper
• Metal complexes of flavonoids: their synthesis, characterization and enhanced antioxidant and anticancer activities.

  2019cites this paper
• MOLECULAR MECHANISMS OF POTENTIAL SYNERGI STIC EFFECT OF KETOPROFEN AND MELOX ICAM WITH CONVENTION AL CYTOSTATICS IN HUMAN CERVIX CANCER CELL LINE

  2018cites this paper
• Methotrexate induces high level of apoptosis in canine lymphoma/leukemia cell lines.

  2017cites this paper
• Synergistic Effect of Carboplatin and Piroxicam on Two Bladder Cancer Cell Lines.

  2017cites this paper
• PHARMACOKINETIC DRUG-DRUG INTERACTIONS EVALUATION OF MELOXICAM WITH SELECTED CO-PRESCRIBED DRUGS

  2017cites this paper
• Synergistic growth inhibitory effect of deracoxib with doxorubicin against a canine mammary tumor cell line, CMT-U27

  2016cites this paper
• Evaluation of the matabolic response of osteosarcoma cells to conventional and new anticancer drugs by NMR metabolomics

  2015cites this paper
• Utilizing the protein corona around silica nanoparticles for dual drug loading and release.

  2015cites this paper
• 3d metal complexes with meloxicam as therapeutic agents in the fight against human glioblastoma multiforme and cervical carcinoma

  2015cites this paper
• Modulatory effects of meloxicam on cardiotoxicity and antitumor activity of doxorubicin in mice

  2014cites this paper
• THERAPEUTIC EVALUATION OF METHOTREXATE WITH OR WITHOUT COX-2 INHIBITOR IN THE MANAGEMENT OF CANINE MAMMARY TUMOURS

  2014cites this paper
• Surface modification and evaluation of PLGA nanoparticles: the effects on cellular uptake and cell proliferation on the HT-29 cell line

  2014cites this paper
• Cytotoxicity enhancement in MDA-MB-231 cells by the combination treatment of tetrahydropalmatine and berberine derived from Corydalis yanhusuo W. T. Wang

  2014cites this paper
• Meloxicam synergistically enhances the in vitro effects of sunitinib malate on bladder-cancer cells

  2013cites this paper
• Preparation and in vitro evaluation of meloxicam-loaded PLGA nanoparticles on HT-29 human colon adenocarcinoma cells

  2012cites this paper
• Effect of COX and LOX inhibitors on melanoma

  2012cites this paper
• A dynamic study on reversal of multidrug resistance by ginsenoside Rh₂ in adriamycin-resistant human breast cancer MCF-7 cells.

  2012cites this paper
• Anti-tumour effects by a trimodal combination of temozolomide, meloxicam and X-rays in cultures of human glioma cells

  2011cites this paper
• Positively charged polymeric nanoparticles: application in improving therapeutic efficacy of meloxicam after oral administration.

  2011cites this paper
• Eudragit EPO nanoparticles: application in improving therapeutic efficacy and reducing ulcerogenicity of meloxicam on oral administration.

  2011cites this paper
• Inhibitory effect of celecoxib combined with cisplatin on growth of human tongue squamous carcinoma Tca8113 cell xenograft tumor

  2010cites this paper
• Synthesis and Structure‐Activity Relationship Studies of Pyrazole‐based Heterocycles as Antitumor Agents

  2010cites this paper
• Celecoxib enhances the inhibitory effect of cisplatin on Tca8113 cells in human tongue squamous cell carcinoma in vivo and in vitro.

  2010cites this paper
• Acetylsalicylic acid regulates MMP-2 activity and inhibits colorectal invasion of murine B16F0 melanoma cells in C57BL/6J mice: effects of prostaglandin F(2)alpha.

  2009cites this paper
• A traditional Chinese medicine formulation consisting of Rhizoma Corydalis and Rhizoma Curcumae exerts synergistic anti-tumor activity.

  2009cites this paper
• Evaluation of the cytotoxicity and genotoxicity of curcumin in PC12 cells.

  2009cites this paper
• In vitro study on the individual and synergistic cytotoxicity of adriamycin and selenium nanoparticles against Bel7402 cells with a quartz crystal microbalance.

  2009cites this paper
• Establishment and characterization of a novel human malignant peripheral nerve sheath tumor cell line, FMS-1, that overexpresses epidermal growth factor receptor and cyclooxygenase-2

  2009cites this paper
• Journal of Intercultural Ethnopharmacology

  year unknowncites this paper